Search for a trial

Upfront autologous hematopoietic stem cell transplantation versus immunosuppressive medication in early diffuse cutaneous systemic sclerosis: an international multicentre, open-label, randomized controlled trial

This study has been transitioned to CTIS with ID 2023-505877-34-00 check the CTIS register for the current data. To determine the optimal treatment strategy in early dcSSc: the effect of HSCT as upfront therapy compared with that of…

Assessment of concentrations of belimumab in body fluids of patients with systemic lupus erythematosus

To determine the concentration of belimumab in blood, saliva and seminal fluid in patients with SLE, treated with intravenous or subcutaneous belimumab.